YLYun Ling

Yun Ling

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yun Ling has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • De-Min Yu

    Clinical Virology Research Laboratory, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, No. 197, Ruijin Er Road, Shanghai, 200025 China

    1 shared publication
  • Dong-Hua Zhang

    Institute of Infectious and Respiratory Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

    1 shared publication
  • Feng Zhou

    Liver Disease Research Center, Nanjing Military Command, Shanghai, China

    1 shared publication
  • Guo-Qing Zang

    Department of Infectious Diseases, No. 6 People's Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China

    1 shared publication
  • Jian-She Wang

    The Center for Pediatric Liver Diseases, Children’s Hospital of Fudan University, Shanghai, China

    1 shared publication
  • Jie Xu

    Department of Infectious Diseases, No. 3 People's Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai China

    1 shared publication

Latest Publications

  • Open Access

    Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations

    by Xin-Hua Li, Yi Lu, Yun Ling, Qing-Chun Fu, Jie Xu, Guo-Qing Zang, Feng Zhou, Yu De-Min, Yue Han, Dong-Hua Zhang, et al.

    Background: Wilson's disease (WND) is a rare autosomal recessive disorder. Here we have evaluated 62 WND cases (58 probands) from the Chinese Han population to expand our knowledge of ATP7B mutations and to more completely characterize WND in China. Methods: The coding and promoter regions of the ATP7B gene were analyzed by direct sequencing in 62 Chinese patients (58 probands) with WND (male, n = 37; female, n = 25; age range, 2 ~ 61 years old). Results: Neurologic manifestations were associated with older age at diagnosis (p < 0.0001) and longer diagnostic delay (p < 0.0001). Age at diagnosis was also correlated with urinary copper concentration (r = 0.58, p < 0.001). Forty different mutations, including 14 novel mutations, were identified in these patients. Common mutations included p.Arg778Leu (31.9%) and p.Pro992Leu (11.2%). Homozygous p.Arg778Leu and nonsense mutation/frameshift mutations were more often associated with primary hepatic manifestations (p = 0.0286 and p = 0.0383, respectively) and higher alanine transaminase levels at diagnosis (p = 0.0361 and p = 0.0047, respectively). Nonsense mutation/frameshift mutations were also associated with lower serum ceruloplasmin (p = 0.0065). Conclusions: We identified 14 novel mutations and found that the spectrum of mutations of ATP7B in China is quite distinct from that of Western countries. The mutation type plays a role in predicting clinical manifestations. Genetic testing is a valuable tool to detect WND in young children, especially in patients younger than 8 years old. Four exons (8, 12, 13, and 16) and two mutations (p.Arg778Leu, p.Pro992Leu) should be considered high priority for cost-effective testing in China.